Circuit Clinical™ has announced a comprehensive partnership with University at Buffalo, part of The State University of New York system, that powers the collection, storage and genetic sequencing of vast numbers of disease-targeted biospecimens to advance innovation in drug discovery.
Founded in 2014, based in Buffalo, New York, Circuit Clinical is an Integrated Research Organization, dedicated to empowering patients choosing clinical research as a care option and transforming the experience of finding and participating in clinical trials.
Founded in 1846 University at Buffalo is a premier, research-intensive public university dedicated to academic excellence and making a positive impact on the world.
The agreement allows Circuit Clinical to collect, store and process blood, tissue and bodily fluids for genomic sequencing and studying of the microbiome in a value-sharing model.
The University at Buffalo biorepository is a state-of-the-art facility located in the Clinical and Translational Science Institute and managed by the New York State Center of Excellence for Bioinformatics & Life Sciences. The biorepository program enables critical clinical science research and diagnostic development, as well as the advancement of precision medicine through deep annotation and “big data” integration.
“This unique partnership greatly expands Circuit Clinical’s capabilities in creating the medical and genomic datasets needed to develop the next generation of American medicines.” … “The goal of these collections is to help the pharmaceutical industry identify important targets and promising therapies in the years ahead.” … “With our network access to more than 1 million patients, this partnership allows Circuit Clinical to provide partners with robust data in a way that prioritizes patient empowerment, ownership, privacy, and transparency.” – Dr. Irfan Khan, CEO of Circuit Clinical
“Circuit Clinical is the ideal partner to collaborate with, given their unique ability to identify and engage with patients interested in donating their biosamples and medical data to drive drug discovery at an early stage.” – Dr. Norma Nowak, executive director of the New York State Center of Excellence in Bioinformatics & Life Sciences